Mulholland has been pushing a different path. It aligns with that of the Australian MD with GBM. Existing agents including CIs combined with AI selected antigen based mRNA platforms (as best I can decode out of nebulous info). The tie in to melanoma is a clue.
Trials @ucl@uclh under Dr Paul Mulholland open in May in memory of my late sister Margaret.
Thank you @ProfRAScolyer for being such a huge inspiration for everyone fighting for a cure for Glioblastoma Brain Tumours! Your treatment is such a force for progress. Trials @ucl@uclh under Dr Paul Mulholland open in May in memory of my late sister Margaret! https://t.co/17lLKtDDzQ